Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
549.64M | 530.10M | 474.37M | 408.35M | 323.51M | 240.63M | Gross Profit |
431.71M | 416.14M | 375.02M | 332.59M | 268.94M | 200.13M | EBIT |
71.30M | 60.39M | 17.09M | 26.89M | -26.41M | -13.88M | EBITDA |
131.10M | 124.35M | 72.06M | 72.53M | 25.55M | 51.83M | Net Income Common Stockholders |
47.04M | 37.80M | 7.24M | 15.37M | -52.44M | -32.37M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
59.12M | 84.47M | 124.76M | 86.88M | 73.21M | 51.73M | Total Assets |
1.13B | 1.15B | 1.19B | 1.17B | 1.13B | 849.58M | Total Debt |
23.98M | 57.75M | 182.68M | 252.89M | 244.77M | 351.40M | Net Debt |
-35.14M | -26.72M | 57.92M | 166.01M | 171.56M | 299.66M | Total Liabilities |
97.33M | 143.56M | 282.27M | 360.47M | 362.35M | 418.10M | Stockholders Equity |
1.04B | 1.01B | 909.46M | 808.22M | 767.19M | 431.48M |
Cash Flow | Free Cash Flow | ||||
91.75M | 77.35M | 97.87M | 55.78M | 49.94M | 24.27M | Operating Cash Flow |
122.56M | 117.90M | 131.62M | 72.47M | 63.59M | 33.94M | Investing Cash Flow |
-41.15M | -40.54M | -34.72M | -18.29M | -200.09M | -9.66M | Financing Cash Flow |
-106.85M | -116.38M | -58.85M | -37.47M | 160.19M | -1.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $2.64B | 94.40 | 4.30% | ― | 5.59% | ― | |
72 Outperform | $1.31B | 27.96 | 4.80% | ― | 13.84% | 1494.51% | |
71 Outperform | $1.26B | 9.63 | 13.46% | ― | -1.18% | 100.33% | |
66 Neutral | $1.19B | 872.55 | 0.19% | ― | 9.86% | ― | |
62 Neutral | $869.09M | ― | -0.29% | ― | 88.81% | 99.16% | |
61 Neutral | $1.07B | 6.96 | -27.42% | ― | 3.64% | 86.92% | |
54 Neutral | HK$64.45B | -1.04 | -1.91% | 7.94% | -2.68% | -14.14% |
On June 17, 2025, Integral Ad Science Inc. entered into a second amendment to its credit agreement with PNC Bank and other financial institutions, extending the maturity date to June 17, 2030, and adding a $30 million sub-facility for swingline loans. This amendment allows IAS to increase its borrowing capacity from $300 million to at least $550 million, supporting its growth and enhancing financial flexibility, as stated by CFO Alpana Wegner.
The most recent analyst rating on (IAS) stock is a Buy with a $16.00 price target. To see the full list of analyst forecasts on Integral Ad Science stock, see the IAS Stock Forecast page.
On June 3, 2025, Integral Ad Science announced the appointment of Alpana Wegner as Chief Financial Officer, effective June 10, 2025. Wegner, who has over 25 years of financial leadership experience, previously served as CFO at Secureworks and Benefitfocus. Her appointment is expected to strengthen IAS’s financial strategy and support its growth ambitions. She will replace Jill Putman, who served as Interim CFO and will continue as an independent board member.
The most recent analyst rating on (IAS) stock is a Buy with a $16.00 price target. To see the full list of analyst forecasts on Integral Ad Science stock, see the IAS Stock Forecast page.
On May 1, 2025, Integral Ad Science Holding Corp. held its Annual Meeting of Shareholders, where key proposals were voted on. Shareholders elected Class I directors to serve until 2028, approved executive compensation on a non-binding advisory basis, and ratified PricewaterhouseCoopers LLP as the independent accounting firm for 2025. These decisions reflect the company’s ongoing governance and operational strategies, potentially impacting its market position and stakeholder confidence.